Comparing ichorbio to Bio X Cell: Industry Pricing
Updated on 22nd April 2021
ichorbio has the same pricing for our academic customers as for our industry customers, whereas Bio X Cell charges a premium to their industry customers.
Comparing pricing of Bio X Cell’s InVivoMab™ antibodies with ichorbio’s Low Endotoxin antibodies
|ichorbio Low Endotoxin Antibodies (USD)||Bio X Cell InVivoMab (TM) Antibodies (USD)||% difference|
Bio X Cell increased their industry prices significantly for their InVivoMab™ antibodies in 2021 and are now 48% more expensive than the exact same clones from ichorbio.
Comparing Pricing of Bio X Cell’s InVivoPlus™ antibodies to ichorbio’s Ultra-Low Endotoxin antibodies
Endotoxin Antibodies (USD)
|Bio X Cell|
InVivoPlus (TM) Antibodies (USD)
Bio X Cell’s 2021 pricing updates for their InVivoPlus™ range of antibodies did not increase as much as their InVivoMab™ range.
Our Ultra-Low endotoxin antibodies are 51% cheaper than BioLegend’s GoInVivo™ antibodies.
Some larger price differences
In the main all of Bio X Cell’s prices follow a similar pattern as listed above. There are a few exceptions however:
- anti-CTLA-4 antibody, clone 9D9 InVivoPlus™ antibody (BP0131)
- anti-PD-L1 antibody, clone 10F.9G2 InVivoPlus™ antibody (BP0101)
- anti-PD-1 antibody, clone RMP1-14 InVivoPlus™ antibody (BP0146)
Ultra-Low Endotoxin antibodies (USD)
|Bio X Cell|
InVivoPlus (TM) antibodies (USD)
ichorbio’s Ultra-Low Endotoxin antibodies are 56% cheaper on average compared to the three Bio X Cell’s InVivoPlus™ antibodies listed above.
For a list of all ichorbio’s directly comparable products to Bio X Cell click here: